WHI SERIES ADVISORY BOARD 2022
WHY ATTEND?
Reproductive health is set to hold a leading market share of the women’s health industry, with an estimated global worth of $171 billion by 2027.
Start-ups, Femtech, and Technology Innovators are driving the acceleration of new and improved solutions for the unmet needs of people’s reproductive health journeys.
The Reproductive Health Innovation Summit (February 15-16) is the destination for uncovering what is next in fertility, contraception and maternal health, from AI and big data to genetic testing, laboratory automation, consumer wearables, non-hormonal devices & solutions and new care delivery models.
Join us to:
Tackle the challenges that straddle the reproductive health sector, including funding, insurance coverage, access and DTC business-models.
Dive into 1 of our 3 leading innovation tracks: Contraception, Fertility or Maternal Health to discover the latest research, innovations and sector-specific challenges and opportunities.
Network with the leaders and changemakers with numerous 1-2-1 opportunities, investor clinics and interactive roundtables throughout the 2 days.
Add to the innovation and attend alongside our leading network of biotechs, start-ups, Femtech, insurers, CROs, investors, medical device companies, researchers, pharmaceuticals, HCPs and advocacy groups to drive innovation at the convergence of healthcare and technology.
2022 Innovation Spotlight
Showcasing the most innovative and disruptive companies in reproductive health.
18 opportunities at this years’ summit!
9 reproductive health focused start-ups, selected by our prestigious Selection Committee, will take to the stage in quick-fire round of presentations, demonstrating their vision of the reproductive health industry of the future, and what role their technology, product, or service plays in that.
3 finalists will be selected from each of the 3 innovation categories: contraception, fertility and maternal health, to give a 3-minute pitch of their company in front of 100s of industry leaders and strategic, corporate partners.
The 3 runners-up in each category will have the opportunity to enter a ‘lightening round’ of 1- minute pitches on-stage.
Applications are stage agnostic, and we encourage anyone to apply with a vision of a better reproductive health industry of the future.
Application deadline: 9th December 2021
Receive $100 off your ticket by applying! APPLY TODAY
All details shared with the committee are strictly confidential. The more detailed application form, the more information the selection committee can use to make their decision. However, if you do not wish to fill in a question, please feel free to leave it blank.
APPLY HERE
2022’S PRESTIGIOUS SELECTION COMMITTEE OF INVESTORS
FREE TO ATTEND WEBINAR
2022 Partners
Platinum Partner
Presagen
Website: https://www.presagen.com/
Presagen is an AI healthcare company focused on improving Women's health outcomes globally. Presagen's Social Network for Healthcare that is changing the way clinics, patients, and medical data from around the world are connected through AI. Our online data-sharing and collaboration network enables clinics and patients to connect, safely share data, use AI healthcare services, and get rewarded. With an initial focus in Women’s Health, Presagen’s first product, Life Whisperer, is being used by IVF clinics globally to improve pregnancy outcomes for patients.
Organon
Website: https://www.organon.com/
Organon (NYSE: OGN) is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives. Here for her health, the company has a portfolio of more than 60 medicines and products across a range of therapeutic areas. Led by the reproductive health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines, Organon’s products produce strong cash flows that will support investments in future growth opportunities in women’s health, including business development. In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialize their products by leveraging its scale and presence in fast growing international markets. Organon has a global footprint with significant scale and geographic reach, world-class commercial capabilities, and approximately 9,000 employees with headquarters located in Jersey City, N.J.
Gold Partner
ICON PLC
Website: https://iconplc.com/
ICON plc is a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations. The company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON employs approximately 16,000 employees in 93 locations in 41 countries. Further information is available at www.iconplc.com.
Granata Bio
Website: https://www.granata.bio/
Granata Bio is a biopharma company focused on women's health and infertility. Founded in 2018, Granata Bio’s model is to identify and in-license strategic products for development and commercialization in North America. The company recently announced a partnership with IBSA Group (Lugano, CH) to co-develop a novel subcutaneous progesterone solution in the United States.
For more information, please visit www.granata.bio. Follow on Twitter, Instagram, and LinkedIn.
Event Partners
Women of Wearables
Website: https://www.womenofwearables.com/
Women of Wearables is the first global organisation that supports and connects women in wearable tech, fashion tech, health tech, IoT and VR/AR.
Its mission is to encourage more women and diverse teams to participate in building hardware and software products as designers, product managers and developers or being founders of their own companies, as well as create more jobs for women in STEM. With headquarters in London (UK) and more than 20,000 members located around the globe, WoW supports its growing community of women and girls in the tech space through monthly meetups, panels, mentorship and collaboration with its network of local ambassadors, partners and communities. WoW is not just for professional women, but for anyone with an interest in emerging technologies and providing women with a platform for growth.
FemTech Focus
Website: www.femtechfocus.org
Femtech Focus is a 501c3 non-profit entity empowering the femtech industry through increased awareness of femtech in the tech world, providing resources to femtech founders, and creating opportunities to support femtech startups through exposure, networking, and access to capital.
How we are contributing to women's health space:
Femtech Focus has a popular podcast with thousands of listeners around the world. This supports our efforts to increase awareness of the femtech industry.
Femtech Focus is launching a femtech accelerator this Fall. Follow our social pages and subscribe to our newsletter to know when applications open!
@FemtechFocus - Facebook, Twitter, Instagram, Linkedin
2022 Speakers
Elena Gambon
Alice Zheng, MD, MBA, MPH
David Sable
Elizabeth Garner
Ru-fong Joanne Cheng
Temitayo Erogbogbo
Kelle Moley, MD
Dr. Kelle Moley is a career physician-scientist obstetrician/gynecologist who currently leads the Reproductive Health Technologies Domain within the Discovery & Translational Sciences, Global Health Division at the Bill and Melinda Gates Foundation. Kelle joined BMGF in July 2020, with a 30-year history of basic and translational research on reproductive health issues in females throughout the life course-- from organismal to cellular and molecular levels of metabolic, developmental biology, embryo implantation and decidualization, and infectious diseases of the female reproductive tract.
Kelle earned her BA from Wellesley College, and her MD from Yale Medical School. Thereafter, she pursued an Obstetrics & Gynecology Residency and a Fellowship in Reproductive Endocrinology & Fertility at Washington University in St. Louis School of Medicine. Kelle then spent the next 3 decades of a thriving research career at Washington University—rising to become the James P. Crane Professor of Obstetrics & Gynecology, Vice Chair of Obstetrics & Gynecology, Chief of the Division of Basic & Translational Research for the Department of Obstetrics & Gynecology, Co-Director of the Institute of Clinical & Translational Science for the School of Medicine, and Director of the Center for Reproductive Health Sciences at the School of Medicine. Her research (published in some 150 peer-reviewed primary articles) led to an international reputation along with numerous honors, including election to the National Academy of Medicine in 2014. She also earned a reputation as a superb mentor to trainees, leading the reproductive endocrinology fellowship program at Washington University until she left academia in 2018. After a 2-year stint as Chief Scientific Officer and Senior Vice President of the March of Dimes she left to pursue her new position at BMGF.
Gregory S. Kopf, PhD
Mikayla Johnson
Dr. Raoul Scherwitzl
Nathanial DeNicola
Dr. Patrick Carroll
Akash Bakshi
Lisa Campo-Engelstein
Sasha Ottey, MHA, MT, (ASCP)
Sateria Venable
Sateria Venable is the Founder & CEO of The Fibroid Foundation (www.fibroidfoundation.org), a global, patient-founded advocacy organization.
The Fibroid Foundation develops programming to support its community of over 25,000 women. Sateria began her advocacy efforts in 2007. Since that time, the organization has developed a substantial network within the medical community.
Venable, who holds a Bachelor of Architecture from Carnegie Mellon University, has co-authored several scientific papers on fibroid research. She is the inventor of an undergarment inspired by her journey, that she hopes will transform intimate apparel for all women. A sought-after speaker, she has been featured in print and radio media, and has presented at gynecologic conferences worldwide.
Amanda Gorman
Sara Naseri
Reenita Das
Sarah Chamberlain
Katie Schubert
Jamie White
Heather Vahdat
Thomas Crouzier
Priyanka Jain
Anula Jayasuriya
Audrey Anderson Duckett
Brian T. Nguyen
Elizabeth Bailey
Linda Greub
David Sable
Emily Zhen
Deena Shakir
Maria Velissaris
Madeleine Livingston
Jackie Rotman
Evan Sussman
Michelle Perugini
Rachel Scherl
Rachel Blank
Katie Williams
Dr. Neel Shah
Download 2022 agenda
Be the first to view our 2021 Reproductive Health Innovation Summit agenda!
Sessions include:
- Investment, Innovation & Reproductive Health: Where does Technology Stand today?
- The IVF Clinic Market of the Future: Exploring the Impact of PE investment
- Male Reproductive Health & The Impact on Women's Health
- Sex & Gender in Medicine, Research & Practice
Our agenda provides all the information you need to book your place at Reproductive Health Innovation Summit USA, access your copy today!
Download the Reproductive Health Innovation Summit Agenda
Returning Safely Measures
Whether sponsors, speakers or attendees, our customers attend Kisaco Research events to connect, learn and innovate to know more and do business. It is our commitment that as we return to in-person events, they can do this effectively, safely and with confidence.
All in-person Kisaco Research events will prioritize the health and safety of colleagues and customers and, in the first instance, will be run in accordance with official government and local authority guidance, as well as any venue or location-specific regulations.
Kisaco Research is committed to following the Association of Event Organisers All Secure Standard, which has been approved by by UK Government.
REGISTRATION
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
TICKET PRICES INCREASE IN
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.